Does high sensitive CRP improve cardiovascular risk prediction in metabolic syndrome among the aged?

Scandinavian Cardiovascular Journal

Volumn 47, Issue 4, 2013, Pages 210-216

  Salminen, Marika ^a,b,c   Kuoppamäki, Marikka ^a,d   Vahlberg, Tero ^a   Räihä, Ismo ^a,e   Irjala, Kerttu ^f   Kivelä, Sirkka Liisa ^a,g  

^a UNIVERSITY OF TURKU   (Finland)

^b Harkatie Health Centre   (Finland)

^c HOSPITAL DISTRICT OF SOUTHWEST FINLAND   (Finland)

^d Naantali Health Centre   (Finland)

^e TURKU CITY HOSPITAL   (Finland)

^f Mehilainen Corporation   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aged; Cardiovascular; High sensitivity C reactive protein; Metabolic syndrome; Mortality

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HEART FAILURE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WORLD HEALTH ORGANIZATION;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84880438970     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2013.798427     Document Type: Article

References (26)

1. S, S ingh U, Jialal I. H uman C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009;20:182-9.
2. Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818-25.
3. Festa A, D 'A gostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102:42-7.
4. Yudkin JS, J uhan-Vague I, Hawe E, Humphries SE, d i Minno G, Margaglione M, et al. Low-grade inflammation may play role in the etiology of the metabolic syndrome in patients with coronary heart disease: The HIFMECH Study. Metabolism. 2004;53:852-7.
5. Vu JD, Vu JB, Pio JR, Malik S, Franklin SS, Chen RS, Wong ND. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adult with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol. 2005;96:655-8.
6. Zuliani G, V olpato S, Galvani M, Blè A, B andinelli S, Corsi AM, et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: the role of central obesity data from the InChianti study. Atherosclerosis. 2009;203:626-32.
7. Freeman D J, Norrie J, Caslake M J, Gaw A, Ford I, Lowe GD, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51:1596-1600.
8. Pischon T, Hu FB, Rexrode KM, Girman C J, Manson JE, Rimm EB. Inflammation, the metabolic syndrome, and the risk of coronary heart disease in women and men. Atherosclerosis. 2008;197:392-9.
9. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, et al. Loci related to metabolic-syndrome pathways including LERP, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women ' s Genome Health Study. Am J Human Gen. 2008;82:1185-92.
10. Sattar N, Gaw A., S cherbakova O, Ford I, O 'R eilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414-9.
11. Takeno M, Yasuda S, Otsuka Y, M orii I, K awamura A, Yano K, Miyazaki S. Impact of metabolic syndrome on the longterm survival of patients with acute myocardial infarction-potential association with C-reactive protein. Circ J. 2008;72:415-9.
12. Jenny NS, French B, Arnold A M, Strotmeyer ES, Cushman M, Chaves PHM, et al. Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol. 2012;67:970-6.
13. Wassel C L, Barrett-Connor E, Laughlin G A. A ssociation of circulating C-reactive protein and interleukin-6 with longevity into 80s and 90s: The Rancho Bernardo Study. J Clin Endocrinol Metab. 2010;95:4748-55.
14. Kizer J R, Arnold AM, Jenny N S, Cushman M, Strotmeyer ES, Ives DG, et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: The Cardiovascular Health Study All Stars Study. J Gerontol. 2011;66A:1100-7.
15. Isoaho R, Puolijoki H, Huhti E, Kivelä S L, L aippala P, T ala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med. 1994;88:571-80.
16. Löppönen M, Räihä I, Isoaho R, V ahlberg T, Kivelä SL. Diagnosing cognitive impairment and dementia in primary health carea more active approach is needed. Age Ageing. 2003;32:606-12.
17. Takala TI, Suominen P, Isoaho R, Kivelä SL, L öppönen M, Peltola O, et al. Iron-replete reference intervals to increase sensitivity of hematologic and iron status laboratory tests in the elderly. Clin Chem. 2002;48:1586-9.
18. Loikas S, Löppönen M, Suominen P, Møller J, Irjala K, Isoaho R, et al. RIA for serum holo-transcobalamin: Method evaluation in the clinical laboratory and reference interval. Clin Chem. 2003;49:455-62.
19. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization;1999.
20. The Emerging Risk Factors Collaboration;Kaptoge S, D i Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Eng J Med 2012;367:1310-20.
21. Alberti K, Zimmet P, Shaw F for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-62.
22. Zimmet P, Magliano D, Matsuzawa Y, A lberti G, Shaw J. T he metabolic syndrome: a global health problem and a new definition. J Atheroscler Thromb. 2005;12:295-300.
23. Baumgartner RN, Stauber PM, M cHugh D, Koehler KM, Garry PJ. Cross-sectional age differences in body composition in persons 60 years of age. J Gerontol Series A Biol Sci Med Sci. 1995;50:M307-16.
24. Bales CW, Ritchie CS. Sarcopenia, weight loss, and nutritional frailty in the elderly. Annual Rev Nutr. 2002;22:309-23.
25. Seidell JC, Visscher TL. Body weight and weight change and their health implications for the elderly. Eur J Clin Nutr. 2000;54:S33-9.
26. Pearson T A, Mensah G A, A lexander R W, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health care. Circulation. 2003;107:499-511.